Literature DB >> 32012448

Impact of systematic segmentectomy for small hepatocellular carcinoma.

Masaki Kaibori1, Kengo Yoshii2, Kiyoshi Hasegawa3, Shunichi Ariizumi4, Tsuyoshi Kobayashi5, Toshiya Kamiyama6, Atsushi Kudo7, Hiroki Yamaue8, Norihiro Kokudo3, Masakazu Yamamoto4.   

Abstract

BACKGROUND: We compared survival after resection by systematic segmentectomy (SS) versus non-anatomic resection (NAR) in patients with small, solitary hepatocellular carcinomas (HCCs).
METHODS: To control for variables, we used 1-to-1 propensity score matching to compare outcomes after surgery among 615 patients in Japan between 2003 and 2007 with primary solitary HCCs ≤3 cm in diameter who received SS (n = 114) or NAR (n = 114) of one Couinaud segment with complete removal of the portal territory containing the tumor.
RESULTS: We successfully matched SS and NAR patients with primary HCC tumors ≤3.0 cm and similar liver function and tumor characteristics. The SS group had significantly longer recurrence-free survival (RFS; hazard ratio [HR] 1.56, 95% confidence interval [CI] 1.10-2.21, P = .013) and overall survival (OS; HR 1.67, 95% CI 1.07-2.60, P = .025) than the NAR group. Among patients who lost >400 mL of blood during surgery, had chronic hepatitis, or had cirrhosis, the RFS and OS were better in the SS group than in the NAR group. In Cox proportional hazard analysis, SS offered a better prognosis than NAR.
CONCLUSIONS: Systematic segmentectomy decreases the risk of recurrence and improves OS in patients with primary, solitary HCC tumors of ≤3 cm in diameter.
© 2020 Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Entities:  

Keywords:  hepatocellular carcinoma; non-anatomic resection; overall survival; recurrence-free survival; systematic segmentectomy

Mesh:

Year:  2020        PMID: 32012448     DOI: 10.1002/jhbp.720

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  4 in total

1.  Total tumor volume as a prognostic value for survival following liver resection in patients with hepatocellular carcinoma. Retrospective cohort study.

Authors:  Hazem M Zakaria; Mahmoud Macshut; Nahla K Gaballa; Ahmed E Sherif; Mohammed E Abdel-Samea; Mohamed Abdel-Samiee; Ibrahim Marwan; Taha Yassein
Journal:  Ann Med Surg (Lond)       Date:  2020-04-07

Review 2.  Near-Infrared Fluorescence Imaging and Photodynamic Therapy for Liver Tumors.

Authors:  Masaki Kaibori; Hisashi Kosaka; Kosuke Matsui; Morihiko Ishizaki; Hideyuki Matsushima; Takumi Tsuda; Hidehiko Hishikawa; Tadayoshi Okumura; Mitsugu Sekimoto
Journal:  Front Oncol       Date:  2021-02-25       Impact factor: 6.244

Review 3.  Efficacy and safety of various primary treatment strategies for very early and early hepatocellular carcinoma: a network meta-analysis.

Authors:  Sha Yang; Huapeng Lin; Jianning Song
Journal:  Cancer Cell Int       Date:  2021-12-19       Impact factor: 5.722

4.  Value of 3D printing technology combined with indocyanine green fluorescent navigation in complex laparoscopic hepatectomy.

Authors:  Jian Cheng; Zhifei Wang; Jie Liu; Changwei Dou; Weifeng Yao; Chengwu Zhang
Journal:  PLoS One       Date:  2022-08-11       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.